Cargando…
The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence
Recently, there has been a great effort to develop tests based on non-invasive urinary biomarkers (NMIBCs). These tests are based on the fact that NMIBCs are heterogeneous at the molecular level and can be divided into different molecular groups useful to predict prognosis and response to treatment....
Autores principales: | Mancini, Mariangela, Righetto, Marialaura, Zumerle, Sara, Montopoli, Monica, Zattoni, Filiberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554931/ https://www.ncbi.nlm.nih.gov/pubmed/32911596 http://dx.doi.org/10.3390/ijms21186542 |
Ejemplares similares
-
Usefulness of the Urine Methylation Test (Bladder EpiCheck(®)) in Follow-Up Patients with Non-Muscle Invasive Bladder Cancer and Cytological Diagnosis of Atypical Urothelial Cells—An Institutional Study
por: Peña, Karla B., et al.
Publicado: (2022) -
Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples
por: Fiorentino, Vincenzo, et al.
Publicado: (2023) -
Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals
por: Gaga, Mina, et al.
Publicado: (2021) -
Checkpoint Inhibition in Bladder Cancer: Clinical Expectations, Current Evidence, and Proposal of Future Strategies Based on a Tumor-Specific Immunobiological Approach
por: Mancini, Mariangela, et al.
Publicado: (2021) -
Gender-Related Approach to Kidney Cancer Management: Moving Forward
por: Mancini, Mariangela, et al.
Publicado: (2020)